Q3 2023 Holdings
Filed 2023-11-13 | 6 holdings | $195.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc.(ACLX) | COMMON STOCK | 03940C100 | $141.6M | 3,946,630 | 72.6% |
| Mineralys Therapeutics(MLYS) | COM | 603170101 | $17.1M | 1,794,600 | 8.7% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $15.4M | 6,526,476 | 7.9% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $15.2M | 4,012,903 | 7.8% |
| Effector Therapeutics Inc | COM | 28202V108 | $4.0M | 6,822,114 | 2.1% |
| Nkarta Inc.(NKTX) | COM | 65487U108 | $1.9M | 1,333,333 | 0.9% |